Jointown Pharmaceutical (600998.SS) Market Update – 22 Oct 2026
Trading Activity (24 h ending 07:04 PM CET)
| Item | Value |
|---|
| Last closing price | CNY 4.92 |
| 24‑hour change | 0 % |
| 24‑hour volume | CNY 113.9 million |
| 24‑hour turnover | CNY 113.9 million |
| Current market capitalization | CNY 24.8 billion |
| Outstanding shares | 5 billion |
| Simple moving average (200 days) | CNY 4.96 |
| 52‑week high | CNY 5.84 (23 Jan 2026) |
| 52‑week low | CNY 4.48 (29 Jun 2026) |
| Monthly performance | +2.46 % (since end‑of‑month) |
Recent Corporate Development
Jointown Pharmaceutical announced progress regarding guarantee arrangements for its subsidiary. The company confirmed that the required disclosures are being prepared and the related documents have been made available for public review. This step is part of Jointown’s effort to strengthen its financial support framework and to comply with regulatory expectations for transparency in subsidiary relationships.
| Ticker | Exchange | Current price | Market cap | P/E ratio | Recent movement |
|---|
| 000811.SZ (Moon Environment Technology) | SZSE | CNY 29.54 | CNY 29.3 bn | 49.57 | Flat |
| 600109.SS (Sinolink Securities) | SSE | CNY 7.99 | CNY 29.5 bn | 11.89 | Flat |
| 600301.SS (Guangxi Huaxi Nonferrous M) | SSE | CNY 46.23 | CNY 29.3 bn | 30.86 | Flat |
| 002244.SZ (Hangzhou Binjiang Real Estate) | SZSE | CNY 9.31 | CNY 29.7 bn | 16.23 | Flat |
| 3347.HK (Hangzhou Tigermed Consulting-H) | HKSE | HKD 38 | HKD 34.8 bn | 286.76 | Up 1.68 % |
Key Notes
- Moon Environment Technology: No change in price; sector activity linked to the 2026 China Ice and Snow Industry Development Research Report, which highlighted a trillion‑yuan scale for the domestic ice‑snow sector. Related companies such as Snowman Group and Ice Wheel Environment experienced share price increases.
- Sinolink Securities: No change in price; commentary highlighted a renewed focus on robotics and AI, noting potential future demand for integrated mechanical‑AI solutions.
- Hangzhou Tigermed Consulting-H: Shares rose 1.68 %. The company announced that its subsidiary, Fangda Holdings, has entered a temporary trading halt on the Hong Kong Stock Exchange pending a disclosure of insider information related to acquisition and merger rules. The halt is not an indication of a future transaction.
Company Profile – Jointown Pharmaceutical
- Headquarters: Hubei, China
- Business Segments: Antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health‑care drugs, and medical instruments.
- Website: www.jzteyao.com.cn
- Listing: Shanghai Stock Exchange, ticker 600998.SS (IPO: 2 Nov 2010)
